Literature DB >> 7962167

Role of active and latent transforming growth factor beta in bone formation.

L F Bonewald1, S L Dallas.   

Abstract

At first reading the statement "TGF beta stimulates bone formation but inhibits mineralization" may appear to be an oxymoron. However, the bone formation process can take weeks to months to complete, and the unique properties of TGF beta allow this factor to be stored in bone matrix in a latent form, ready to be activated and inactivated at key, pivotal stages in this long process. TGF beta may act to trigger the cascade of events that ultimately leads to new bone formation. However, once this process is initiated, TGF beta must then be inactivated or removed because if present in the later stages of bone formation, mineralization will be inhibited. The unique properties of TGF beta and its role in bone remodeling are the subject of this review.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962167     DOI: 10.1002/jcb.240550312

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  55 in total

1.  Transcription factor Smad3 is required for the inhibition of adipogenesis by retinoic acid.

Authors:  François Marchildon; Catherine St-Louis; Rahima Akter; Victoria Roodman; Nadine L Wiper-Bergeron
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

2.  Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses.

Authors:  Jeoung Soo Lee; Dina M Basalyga; Agneta Simionescu; Jason C Isenburg; Dan T Simionescu; Narendra R Vyavahare
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  The effect of mesenchymal stem cells delivered via hydrogel-based tissue engineered periosteum on bone allograft healing.

Authors:  Michael D Hoffman; Chao Xie; Xinping Zhang; Danielle S W Benoit
Journal:  Biomaterials       Date:  2013-08-16       Impact factor: 12.479

4.  Comparative effect of human platelet derivatives on proliferation and osteogenic differentiation of menstrual blood-derived stem cells.

Authors:  Somaieh Kazemnejad; Roghaieh Najafi; Amir Hassan Zarnani; Saman Eghtesad
Journal:  Mol Biotechnol       Date:  2014-03       Impact factor: 2.695

5.  Src is a major signaling component for CTGF induction by TGF-beta1 in osteoblasts.

Authors:  X Zhang; J A Arnott; S Rehman; W G Delong; A Sanjay; F F Safadi; S N Popoff
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

6.  Osteoblast maturation on microtextured titanium involves paracrine regulation of bone morphogenetic protein signaling.

Authors:  Rene Olivares-Navarrete; Sharon L Hyzy; Qingfen Pan; Ginger Dunn; Joseph K Williams; Zvi Schwartz; Barbara D Boyan
Journal:  J Biomed Mater Res A       Date:  2014-09-06       Impact factor: 4.396

7.  Aging negatively impacts the ability of megakaryocytes to stimulate osteoblast proliferation and bone mass.

Authors:  Kevin A Maupin; Evan R Himes; Artur P Plett; Hui Lin Chua; Pratibha Singh; Joydeep Ghosh; Safa F Mohamad; Irushi Abeysekera; Alexa Fisher; Carol Sampson; Jung-Min Hong; Paul Childress; Marta Alvarez; Edward F Srour; Angela Bruzzaniti; Louis M Pelus; Christie M Orschell; Melissa A Kacena
Journal:  Bone       Date:  2019-07-09       Impact factor: 4.398

8.  TGF-β1 as possible link between loss of bone mineral density and chronic inflammation.

Authors:  Sabrina Ehnert; Johannes Baur; Andreas Schmitt; Markus Neumaier; Martin Lucke; Steven Dooley; Helen Vester; Britt Wildemann; Ulrich Stöckle; Andreas K Nussler
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

Review 9.  Growth factor regulation of proliferation and survival of multipotential stromal cells.

Authors:  Melanie Rodrigues; Linda G Griffith; Alan Wells
Journal:  Stem Cell Res Ther       Date:  2010-10-26       Impact factor: 6.832

10.  Unusual association between enchondroma and Camurati-Engelmann disease: a case report.

Authors:  Hiroyuki Nagasawa; Kyoji Okada; Hiroshi Nanjo; Hiroshi Sasaki; Shuichi Chida; Yoichi Shimada
Journal:  Ups J Med Sci       Date:  2010-05       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.